Literature DB >> 35821917

Quality of Life Improvement Following Reconstruction of Midtarsal Charcot Foot Deformity: A Five Year Follow-Up.

Patrick Cole McGregor1, Madeline M Lyons1, Michael S Pinzur1.   

Abstract

Background: There is increasing interest in reconstruction of diabetes-associated Charcot foot arthropathy with the goal of improving quality of life.
Methods: Twenty-four patients who completed the Short Musculoskeletal Function Assessment (SMFA) at baseline and one year following Charcot foot reconstruction were contacted and asked to complete the survey at five years following surgery.
Results: Fourteen of the 24 patients completed the SMFA preoperatively, one year following surgery and five years postoperatively. Two patients underwent below knee amputation in the interim. Improvement was noted in all domains measured by the SMFA, with a statistically significant improvement in difficulty with daily activities at five years.
Conclusion: Correction of non-plantigrade Charcot foot arthropathy results in clinically meaningful improvement in health-related quality of life at both one and five years postoperatively, including independence with daily activities. The improvement is maintained when reevaluated at five years. This supports the modern paradigm shift towards reconstruction of this deformity. Level of Evidence: III.
Copyright © The Iowa Orthopaedic Journal 2022.

Entities:  

Keywords:  charcot foot; diabetes; quality of life

Mesh:

Year:  2022        PMID: 35821917      PMCID: PMC9210442     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  16 in total

1.  Charcot neuroarthropathy of the foot and ankle.

Authors:  L C Schon; M E Easley; S B Weinfeld
Journal:  Clin Orthop Relat Res       Date:  1998-04       Impact factor: 4.176

2.  Deformity and Clinical Outcomes Following Operative Correction of Charcot Foot: A New Classification With Implications for Treatment.

Authors:  Michael S Pinzur; Adam P Schiff
Journal:  Foot Ankle Int       Date:  2017-11-27       Impact factor: 2.827

3.  Short musculoskeletal function assessment questionnaire: validity, reliability, and responsiveness.

Authors:  M F Swiontkowski; R Engelberg; D P Martin; J Agel
Journal:  J Bone Joint Surg Am       Date:  1999-09       Impact factor: 5.284

4.  Surgical Management of Charcot Arthropathy.

Authors:  Carroll Jones; Jeremy J McCormick; Michael S Pinzur
Journal:  Instr Course Lect       Date:  2018-02-15

5.  Progression of foot deformity in Charcot neuropathic osteoarthropathy.

Authors:  Mary K Hastings; Jeffrey E Johnson; Michael J Strube; Charles F Hildebolt; Kathryn L Bohnert; Fred W Prior; David R Sinacore
Journal:  J Bone Joint Surg Am       Date:  2013-07-03       Impact factor: 5.284

6.  Clinical Outcomes and Complications of Midfoot Charcot Reconstruction With Intramedullary Beaming.

Authors:  Samuel E Ford; Bruce E Cohen; W Hodges Davis; Carroll P Jones
Journal:  Foot Ankle Int       Date:  2018-10-04       Impact factor: 2.827

7.  Improvement in Quality of Life Following Operative Correction of Midtarsal Charcot Foot Deformity.

Authors:  Ellen Kroin; Edwin O Chaharbakhshi; Adam Schiff; Michael S Pinzur
Journal:  Foot Ankle Int       Date:  2018-04-02       Impact factor: 2.827

8.  Health-related quality of life in patients with Charcot foot.

Authors:  Michael S Pinzur; Andrew Evans
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2003-10

9.  Charcot foot reconstruction outcomes: A systematic review.

Authors:  Joon Ha; Thomas Hester; Robert Foley; Ines L H Reichert; Prashanth R J Vas; Raju Ahluwalia; Venu Kavarthapu
Journal:  J Clin Orthop Trauma       Date:  2020-04-20

10.  The Charcot foot in diabetes.

Authors:  Lee C Rogers; Robert G Frykberg; David G Armstrong; Andrew J M Boulton; Michael Edmonds; Georges Ha Van; Agnes Hartemann; Frances Game; William Jeffcoate; Alexandra Jirkovska; Edward Jude; Stephan Morbach; William B Morrison; Michael Pinzur; Dario Pitocco; Lee Sanders; Dane K Wukich; Luigi Uccioli
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.